Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xeris Biopharma Holdings, Inc. XERS

Full chart Compare
Set alert

Price alert · XERS

All alert types
13.08 USD +2.62 (+25.05%)

At closeNov 5, 2026, 4:35 PM EST

13.00 -0.08 -0.61%

After hours · Nov 5, 4:35 PM ET

12.32 Day range 13.74
5.25 52-week range 13.74
YTD
+66.62%
1 year
+32.52%

Financial health

Altman Z-Score

4.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 2243×
FY 2016: -2.8×FY 2017: -1.5×FY 2018: -3.4×FY 2019: -2.0×FY 2020: -2.3×FY 2021: -1.9×FY 2022: -1.9×FY 2023: -5.2×FY 2024: -9.2×FY 2025: 2243×
FY 2016 5y median -1.9× FY 2025
P/S 4.3×
FY 2016: 34.7×FY 2017: 26.4×FY 2018: 83.1×FY 2019: 67.6×FY 2020: 10.3×FY 2021: 4.7×FY 2022: 1.6×FY 2023: 2.0×FY 2024: 2.5×FY 2025: 4.3×
FY 2016 5y median 2.5× FY 2025
P/B 92.0×
FY 2016: -1.2×FY 2017: -0.7×FY 2018: 2.7×FY 2019: 12.8×FY 2020: 6.2×FY 2021: 2.4×FY 2022: 4.0×FY 2023: -47.7×FY 2024: -16.8×FY 2025: 92.0×
FY 2016 5y median 2.4× FY 2025
P/FCF 45.1×
FY 2016: -2.3×FY 2017: -1.6×FY 2018: -3.5×FY 2019: -2.3×FY 2020: -2.6×FY 2021: -2.4×FY 2022: -1.7×FY 2023: -6.6×FY 2024: -13.1×FY 2025: 45.1×
FY 2016 5y median -2.4× FY 2025
EV/EBITDA 93.3×
FY 2016: -0.4×FY 2017: 0.0×FY 2018: -3.3×FY 2019: -1.9×FY 2020: -3.3×FY 2021: -2.2×FY 2022: -3.7×FY 2023: -20.4×FY 2024: -49.8×FY 2025: 93.3×
FY 2016 5y median -3.7× FY 2025
EV/Sales 4.1×
FY 2016: 4.6×FY 2017: -0.7×FY 2018: 77.5×FY 2019: 81.9×FY 2020: 12.7×FY 2021: 5.1×FY 2022: 2.3×FY 2023: 3.0×FY 2024: 3.4×FY 2025: 4.1×
FY 2016 5y median 3.4× FY 2025
FCF Yield 2.2%
FY 2016: -43.3%FY 2017: -61.8%FY 2018: -28.2%FY 2019: -44.0%FY 2020: -38.6%FY 2021: -41.7%FY 2022: -57.3%FY 2023: -15.2%FY 2024: -7.6%FY 2025: 2.2%
FY 2016 5y median -15.2% FY 2025

Profitability

Gross Margin 81.7%
FY 2016: 99.3%FY 2017: 99.7%FY 2018: 98.3%FY 2019: 41.1%FY 2020: 54.4%FY 2021: 73.1%FY 2022: 79.5%FY 2023: 82.5%FY 2024: 81.9%FY 2025: 81.7%
FY 2016 5y median 81.7% FY 2025
Operating Margin 8.5%
FY 2016: -1230.8%FY 2017: -1711.4%FY 2018: -2407.5%FY 2019: -4496.0%FY 2020: -408.8%FY 2021: -232.2%FY 2022: -74.3%FY 2023: -26.8%FY 2024: -16.6%FY 2025: 8.5%
FY 2016 5y median -26.8% FY 2025
Net Margin 0.2%
FY 2016: -1228.7%FY 2017: -1706.6%FY 2018: -2437.3%FY 2019: -4613.5%FY 2020: -446.0%FY 2021: -247.5%FY 2022: -85.9%FY 2023: -38.0%FY 2024: -27.0%FY 2025: 0.2%
FY 2016 5y median -38.0% FY 2025
ROE 4.0%
FY 2016: 41.4%FY 2017: 45.9%FY 2018: -79.7%FY 2019: -869.9%FY 2020: -270.0%FY 2021: -128.9%FY 2022: -209.5%FY 2023: 917.9%FY 2024: 185.2%FY 2025: 4.0%
FY 2016 5y median 4.0% FY 2025
ROIC 8.9%
FY 2016: -42.7%FY 2017: -66.3%FY 2018: -54.0%FY 2019: -149.3%FY 2020: -63.7%FY 2021: -51.1%FY 2022: -29.6%FY 2023: -18.7%FY 2024: -13.3%FY 2025: 8.9%
FY 2016 5y median -18.7% FY 2025
ROA 0.1%
FY 2016: -39.4%FY 2017: -59.0%FY 2018: -50.1%FY 2019: -115.2%FY 2020: -57.3%FY 2021: -40.3%FY 2022: -27.5%FY 2023: -19.3%FY 2024: -17.0%FY 2025: 0.1%
FY 2016 5y median -19.3% FY 2025

Growth (YoY)

Revenue 43.7%
FY 2016: 0.0%FY 2017: 44.7%FY 2018: 58.4%FY 2019: 10.4%FY 2020: 650.7%FY 2021: 142.7%FY 2022: 122.3%FY 2023: 48.7%FY 2024: 23.9%FY 2025: 43.7%
FY 2016 FY 2025
Operating Income 174.0%
FY 2016: 0.0%FY 2017: -101.3%FY 2018: -122.9%FY 2019: -106.2%FY 2020: 31.7%FY 2021: -37.8%FY 2022: 28.8%FY 2023: 46.3%FY 2024: 23.5%FY 2025: 174.0%
FY 2016 FY 2025
EPS (diluted) 100.9%
FY 2016: 0.0%FY 2017: -82.6%FY 2018: 61.9%FY 2019: 30.1%FY 2020: 38.7%FY 2021: 27.6%FY 2022: 54.8%FY 2023: 35.7%FY 2024: 17.8%FY 2025: 100.9%
FY 2016 FY 2025
Free Cash Flow 173.8%
FY 2016: 0.0%FY 2017: -57.3%FY 2018: -127.8%FY 2019: -40.1%FY 2020: 0.0%FY 2021: -19.4%FY 2022: -7.0%FY 2023: 52.3%FY 2024: 23.2%FY 2025: 173.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 13.1×FY 2017: 9.1×FY 2018: 11.6×FY 2019: 3.2×FY 2020: 5.4×FY 2021: 1.8×FY 2022: 2.5×FY 2023: 1.6×FY 2024: 1.7×FY 2025: 2.2×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 1.6×
FY 2016: 13.1×FY 2017: 9.1×FY 2018: 11.6×FY 2019: 3.1×FY 2020: 5.1×FY 2021: 1.6×FY 2022: 2.2×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 1.6×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 2.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.4×FY 2019: 4.0×FY 2020: 2.6×FY 2021: 0.9×FY 2022: 4.4×FY 2023: -33.8×FY 2024: -9.2×FY 2025: 2.8×
FY 2016 5y median 0.9× FY 2025
Net Debt / EBITDA -5.8×
FY 2016: 2.5×FY 2017: 1.6×FY 2018: 0.2×FY 2019: -0.3×FY 2020: -0.6×FY 2021: -0.2×FY 2022: -1.1×FY 2023: -6.8×FY 2024: -14.3×FY 2025: -5.8×
FY 2016 5y median -5.8× FY 2025
Interest Coverage 0.9×
FY 2016: -6616×FY 2017: -13315×FY 2018: -23.3×FY 2019: -17.1×FY 2020: -11.4×FY 2021: -16.0×FY 2022: -5.8×FY 2023: -1.7×FY 2024: -1.0×FY 2025: 0.9×
FY 2016 5y median -1.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31